Impact of Inspired Oxygen Fraction on Outcome in Patients With Traumatic Brain Injury

NCT ID: NCT01201291

Last Updated: 2018-08-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

67 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-11-30

Study Completion Date

2018-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of the study is to investigate the impact of two different fractions of inspired oxygen (FiO2) on outcome in patients with severe traumatic brain injury (TBI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The high oxygen group is treated during mechanical ventilation with either a fraction of inspired oxygen of 0.7 (high oxygen group) or a fraction of inspired oxygen 0.4 (control group). The intervention continues until withdrawal of mechanical ventilation, ICU discharge or until 14 days from ICU randomisation.

Primary outcome is worse than expected outcome in the corresponding treatment arms based on outcome meas-ured by the probability of bad outcome using the CRASH® risk calculator (prognostic model for predicting outcome after traumatic brain injury).

Secondary outcome is occurence of lung injury during mechanical ventilation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury | Patient

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fraction of inspired oxygen of 0.4

Fraction of inspired normobaric oxygen of 0.4 (low oxygen group)

Group Type ACTIVE_COMPARATOR

Normobaric oxygen

Intervention Type OTHER

Fraction of inspired oxygen

Fraction of inspired oxygen of 0.7

Fraction of inspired normobaric oxygen of 0.7 (high oxygen group)

Group Type ACTIVE_COMPARATOR

Normobaric oxygen

Intervention Type OTHER

Fraction of inspired oxygen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Normobaric oxygen

Fraction of inspired oxygen

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with isolated non-penetrating traumatic brain injury
* Multiple trauma patient with brain injury and traumas outside abdomen, thorax or pelvis not affecting oxygenation
* Glasgow coma scale eight or less (inclusive)
* Expected need for intubation and for mechanical ventilation more than 24 hours.
* Are recruited \<18 hours after admittance to ICU and
* Time from TBI is less than 36 hours
* Informed consent from patients representative

Exclusion Criteria

* Age \<18 or \>65 years,
* Anticipated brain death in 12 hours (donor treatment) or otherwise moribund patient expected to die in 24 hours
* Expected need for mechanical ventilation less than 24 hours
* Insufficient oxygenation assessed by a clinician or multiple trauma patients with brain injury and severe abdominal, thoracic or pelvic injury possibly affecting oxygenation.
* No consent
* Insufficient oxygenation with the treatment modality of the lower oxygenation group (Pa02 less than 13 kPa or SpO2 95% with Fi02 40%, PEEP 10 or less) or oxygenation failure probable during ICU care (severe aspiration, multiple trauma patients with brain injury and severe abdominal, thoracic or pelvic injury possibly affecting oxygenation)
* Penetrating TBI
* No consent
* Suspected pregnancy (perform urinary or serological pregnancy test if suspected)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tampere University Hospital

OTHER

Sponsor Role collaborator

Turku University Hospital

OTHER_GOV

Sponsor Role collaborator

Helsinki University Central Hospital

OTHER

Sponsor Role collaborator

Kuopio University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stepani Bendel

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Esko Ruokonen, Professor

Role: PRINCIPAL_INVESTIGATOR

Kuopio University Hospital

Stepani J Bendel, MD,PhD

Role: STUDY_DIRECTOR

Kuopio University Hospital

Maarit Lång, MD

Role: PRINCIPAL_INVESTIGATOR

Kuopio University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Helsinki University Central Hospital, Töölö Hospital

Helsinki, Töölö, Finland

Site Status

Kuopio University Hospital

Kuopio, , Finland

Site Status

Tampere University Hospital

Tampere, , Finland

Site Status

Turku University Hospital

Turku, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KUH5070218

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Blood Flow Restriction Concussion
NCT03695042 TERMINATED NA